Evidence map›Paper›PMID 19210013›Full record

Trial reportHealth psychology : official journal of the Division of Health Psychology, American Psychological Association2009

Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: impact on measures of decision making and satisfaction.

Marc D Schwartz, Heiddis B Valdimarsdottir, Tiffani A DeMarco, Beth N Peshkin, William Lawrence, Jessica Rispoli, Karen Brown, Claudine Isaacs, Suzanne O'Neill, Rebecca Shelby and 8 more

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Health psychology : official journal of the Division of Health Psychology, American Psychological Association, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 9 pooled it
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 9 syntheses or guidelines pooled it, 111 citations in OpenAlex.

  1. Decision aids for people facing health treatment or screening decisions.The Cochrane database of systematic reviews · 2024
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Decision aids for people facing health treatment or screening decisions.The Cochrane database of systematic reviews · 2017
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Clinical decision support for genetically guided personalized medicine: a systematic review.Journal of the American Medical Informatics Association : JAMIA
    Pooled it
  10. Trial
  11. Trial
  12. The Genetic Education for Men (GEM) Trial: Development of Web-Based Education for Untested Men in BRCA1/2-Positive Families.Journal of cancer education : the official journal of the American Association for Cancer Education · 2021
    Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Randomized controlled trial of a psychosocial telephone counseling intervention in BRCA1 and BRCA2 mutation carriers.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2010
    Trial
  18. Longitudinal changes in patient distress following interactive decision aid use among BRCA1/2 carriers: a randomized trial.Medical decision making : an international journal of the Society for Medical Decision Making
    Trial
  19. Article
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Marc D SchwartzCancer Control Program, Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University.
Heiddis B ValdimarsdottirDepartment of Oncological Sciences, Mount Sinai School of Medicine.
Tiffani A DeMarcoCancer Control Program, Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University.
Beth N PeshkinCancer Control Program, Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University.
William LawrenceCancer Control Program, Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University.
Jessica RispoliDepartment of Genetics and Genomic Sciences, Mount Sinai School of Medicine.
Karen BrownDepartment of Genetics and Genomic Sciences, Mount Sinai School of Medicine.
Claudine IsaacsCancer Control Program, Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University.
Suzanne O'Neill
Rebecca ShelbyDepartment of Psychiatry and Behavioral Sciences, Duke University.
Sherry C Grumet
Margaret M McGovernDepartment of Genetics and Genomic Sciences, Mount Sinai School of Medicine.
Sarah GarnettCancer Control Program, Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University.ORCID 0000-0001-7552-0789
Heather BremerCancer Control Program, Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University.
Suzanne LeamanCancer Control Program, Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University.
Kathryn O'MaraCancer Control Program, Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University.
Sarah KelleherCancer Control Program, Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University.
Kathryn KomaridisCancer Control Program, Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University.
Georgetown University · USIcahn School of Medicine at Mount Sinai · USDuke University · US

Funding

INTERACTIVE DECISION AID FOR BRCA 1/2 MUTATION CARRIERSR01CA082346 · NCI · GEORGETOWN UNIVERSITY · PI SCHWARTZ, MARC D · 1999 to 2003
$2.1M
NCI NIH HHS R01 CA01846NCI NIH HHS R01 CA082346
6 · The paper itself

Abstract

objectiveGenetic testing is increasingly part of routine clinical care for women with a family history of breast cancer. Given their substantially elevated risk for breast cancer, BRCA1/BRCA2 mutation carriers must make the difficult decision whether or not to opt for risk reducing mastectomy. To help BRCA1/2 carriers make this decision, the authors developed a computer-based interactive decision aid that was tested against usual care in a randomized controlled trial.

designAfter the completion of genetic counseling, 214 female (aged 21-75) BRCA1/BRCA2 mutation carriers were randomized to Usual Care (UC; N = 114) or Usual Care plus Decision Aid (DA; N = 100) arms. UC participants received no additional intervention. DA participants were sent the CD-ROM DA to view at home.

main outcome measuresThe authors measured final management decision, decisional conflict, decisional satisfaction, and receipt of risk reducing mastectomy at 1-, 6-, and 12-months postrandomization.

resultsLongitudinal analyses revealed that the DA was effective among carriers who were initially undecided about how to manage their breast cancer risk. Within this group, the DA led to an increased likelihood of reaching a management decision (OR = 3.09, 95% CI = 1.62, 5.90; p < .001), decreased decisional conflict (B = -.46, z = -3.1, p <002), and increased satisfaction (B = .27, z = 3.1, p = .002) compared to UC. Among carriers who had already made a management decision by the time of randomization, the DA had no benefit relative to UC.

conclusionThese results demonstrate that BRCA1/BRCA2 mutation carriers who are having difficulty making a breast cancer risk management decision can benefit from adjunct decision support.

Indexed as

Decision MakingGenes, BRCA1Genes, BRCA2Patient SatisfactionAdultAgedBreast NeoplasmsFemaleGenetic CounselingGenetic TestingHumansMastectomyMiddle AgedRisk Assessment

Identifiers

PMID19210013
PMCPMC3580845
OpenAlexW2090377620

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.